Lee, M.-S.; Lee, H.-Y.; Oh, S.-H.; Kim, C.-B.; Kim, J.-H.; Yoo, S.-H.; Yoo, Y.-J.; Lee, S.-Y.; Lee, B.-C.
Salvia miltiorrhiza and Its Compounds as Complementary Therapy for Dyslipidemia: A Meta-Analysis of Clinical Efficacy and In Silico Mechanistic Insights. Pharmaceuticals 2024, 17, 1426.
https://doi.org/10.3390/ph17111426
AMA Style
Lee M-S, Lee H-Y, Oh S-H, Kim C-B, Kim J-H, Yoo S-H, Yoo Y-J, Lee S-Y, Lee B-C.
Salvia miltiorrhiza and Its Compounds as Complementary Therapy for Dyslipidemia: A Meta-Analysis of Clinical Efficacy and In Silico Mechanistic Insights. Pharmaceuticals. 2024; 17(11):1426.
https://doi.org/10.3390/ph17111426
Chicago/Turabian Style
Lee, Min-Seong, Han-Young Lee, Seung-Hyun Oh, Chang-Bum Kim, Ji-Han Kim, Seung-Hoon Yoo, Yeon-Joo Yoo, Su-Yeon Lee, and Byung-Cheol Lee.
2024. "Salvia miltiorrhiza and Its Compounds as Complementary Therapy for Dyslipidemia: A Meta-Analysis of Clinical Efficacy and In Silico Mechanistic Insights" Pharmaceuticals 17, no. 11: 1426.
https://doi.org/10.3390/ph17111426
APA Style
Lee, M.-S., Lee, H.-Y., Oh, S.-H., Kim, C.-B., Kim, J.-H., Yoo, S.-H., Yoo, Y.-J., Lee, S.-Y., & Lee, B.-C.
(2024). Salvia miltiorrhiza and Its Compounds as Complementary Therapy for Dyslipidemia: A Meta-Analysis of Clinical Efficacy and In Silico Mechanistic Insights. Pharmaceuticals, 17(11), 1426.
https://doi.org/10.3390/ph17111426
